NA
OFIX icon

Navellier & Associates’s Orthofix Medical OFIX Stock Holding History

Navellier & Associates’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,000
Closed -$294K – 330
2018
Q1 		$294K Buy
+5,000
New +$280K 0.04% 230

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Navellier & Associates's OFIX Position: Q2 2018 in Review

Navellier & Associates sold out of Orthofix Medical (OFIX) in Q2 2018, closing a stake of 5,000 shares — an estimated $294K sold.

Navellier & Associates first reported a position in OFIX in Q1 2018 and held it in 1 quarter. The position peaked at $294K in Q1 2018. 163 funds tracked by Wall St. Rank hold OFIX as of Q2 2018.

  • Navellier & Associates reported no remaining Orthofix Medical position as of Q2 2018 after selling out during the quarter.
  • Navellier & Associates sold 5,000 Orthofix Medical shares in Q2 2018, an estimated $294K.
  • Navellier & Associates first reported a position in Orthofix Medical in Q1 2018 and held it in 1 quarter.
  • Navellier & Associates's Orthofix Medical position peaked at $294K in Q1 2018.
  • 163 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2018.

Based on Navellier & Associates's 13F filing for Q2 2018, filed 6 Aug 2018.